SEARCH

SEARCH BY CITATION

References

  • 1
    Constitution of the World Health Organization. Handbook of basic documents. Geneva: Palais des Nations, World Health Organization, 1952: 320.
  • 2
    Testa MA, Simonson DC. Assesment of quality-of-life outcomes. N Engl J Med 1996;334:835840.
  • 3
    Johansson Sgo, O'B Hourihane J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813824.
  • 4
    Dykewicz MS, Fineman S. Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis. Ann Allergy Asthma Immunol 1998;81:463468.
  • 5
    International Rhinitis Management Working Group . International Consensus Report on the diagnosis and management of rhinitis. Lund V. et al. Allergy 1994;49:134.
  • 6
    Canonica WG, Holgate ST, et al. The impact of allergic rhinitis on quality of life and other airway diseases. Summary of a European conference. Allergy 1998;53:131.
  • 7
    Boulet LP, Becker A, Berube D, Beveridge R, Ernst P. Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. Can Med Assoc J 1999;161:S1S61.
  • 8
    Motala C, Kling S, Gie R, et al. Guideline for the management of chronic asthma in children – 2000 update. Allergy Society of South Africa Working Group. S Afr Med J 2000;90:524528.
  • 9
    Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis 1993;147:832838.
  • 10
    Hyland ME. The Living with Asthma Questionnaire. Respir Med 1991;85:1316, 33–37.
  • 11
    Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:13211327.
  • 12
    Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991;21:7783.
  • 13
    Bousquet J, Knani J, Dhivert H et al. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med 1994;149:371375.
  • 14
    Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994;94:182188.
  • 15
    Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210216.
  • 16
    Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995;132:942949.
  • 17
    Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol 1997;37:4150.
  • 18
    Cramer JA, Spilker B. Quality of life and Pharmacoeconomics. Philidelphia: Lippincot-Raven, 1998.
  • 19
    Juniper EF, Guyatt GH, Streiner DL, King DR. Clinical impact versus factor analysis for quality of life questionnaire construction. J Clin Epidemiol 1997;50:233238.
  • 20
    Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Status Survey (sF-36). 1. Conceptual framework and item selection. Med Care 1992;30:473483.
  • 21
    Bousquet J, Duchateau J, Pignat JC, et al. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. J Allergy Clin Immunol 1996;98:309316.
  • 22
    Bergner M, Bobbitt RA, Kressel S, Pollard WE, Gilson BS, Morris JR. The sickness impact profile. conceptual formulation and methodology for the development of a health status measure. Int J Health Serv 1976;6:393415.
  • 23
    Hunt SM, McEwen J, McKenna SP. Measuring Health Status. London: Croom-Helm, 1986.
  • 24
    Rutten-van Molken MP, Custers F, Van D oorslaer EK et al. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J 1995;8:888898.
  • 25
    Salek MS, Finlay AY, Luscombe DK, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial. Br J Dermatol 1993;129:422430.
  • 26
    Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol 1999;52:187192.
  • 27
    Marks GB, Dunn SM, Woolcock AJ. An evaluation of an asthma quality of life questionnaire as a measure of change in adults with asthma. J Clin Epidemiol 1993;46:11031111.
  • 28
    Rowe BH, Oxman AD. Performance of an asthma quality of life questionnaire in an outpatient. Am Rev Respir Dis 1993;148:675681.
  • 29
    Badia X, Mascaro JM, Lozano R. Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. The Cavide Res Group. Br J Dermatol 1999;141:698702.
  • 30
    Van S chayck CP, Dompeling E, Rutten MP, Folgering H, Van Den B oom G, Van W eel C. The influence of an inhaled steroid on quality of life in patients with asthma or COPD. Chest 1995;107:11991205.
  • 31
    Austin JK, Smith MS, Risinger MW, McNelis AM. Childhood epilepsy and asthma: comparison of quality of life. Epilepsia 1994;35:608615.
  • 32
    Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47:7683.
  • 33
    Juniper EF, Buist AS. Health-related quality of life in moderate asthma: 400 µg hydrofluoroalkane beclomethasone dipropionate vs 800 µg chlorofluorocarbon beclomethasone dipropionate. The Study Group. Chest 1999;116:12971303.
  • 34
    Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 1999;115:12651270.
  • 35
    Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994;47:8187.
  • 36
    Fayers PM, Machin D. Quality of Life. Assessment, analysis and interpretation. Chichester: John Wiley & Sons Ltd 2000.
  • 37
    Mancuso CA, Peterson MG, Charlson ME. Comparing discriminative validity between a disease-specific and a general health scale in patients with moderate asthma. J Clin Epidemiol 2001;54:263274.
  • 38
    Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol 1992;45:461472.
  • 39
    Juniper EF, Guyatt GH, Andersson B, Ferrie PJ. Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Ann Allergy 1993;70:225230.
  • 40
    Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994;93:413423.
  • 41
    Juniper EF, Howland WC, Roberts NB, Thompson AK, King DR. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol 1998;101:163170.
  • 42
    Kurwa HA, Finlay AY. Dermatology in-patient management greatly improves life quality. Br J Dermatol 1995;133:575578.
  • 43
    Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease. reliability, validity, and responsiveness. J Invest Dermatol 1996;107:707713.
  • 44
    Morgan M, McCreedy R, Simpson J, Hay RJ. Dermatology quality of life scales – a measure of the impact of skin diseases. Br J Dermatol 1997;136:202206.
  • 45
    Oude Elberink J, De M onchy J, Guyatt G, Dubois A. Venom-immunotherapy (VIT) improves health-related quality of life (HRQL) in patients with allergic reactions following yellow-jacket stings. Allergy 1999;54:5.
  • 46
    Juniper EF. Impact of upper respiratory allergic diseases on quality of life. J Allergy Clin Immunol 1998;101:S386S391.
  • 47
    Van Der M olen T, Postma DS, Schreurs AJ, Bosveld HE, Sears MR, Meyboom de Jong B. Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma. Qual Life Res 1997;6:353361.
  • 48
    Malo JL, Boulet LP, Dewitte JD et al. Quality of life of subjects with occupational asthma. J Allergy Clin Immunol 1993;91:11211127.
  • 49
    Moy ML, Israel E, Weiss ST, Juniper EF, Dube L, Drazen JM. Clinical predictors of health-related quality of life depend on asthma severity. Am J Respir Crit Care Med 2001;163:924929.
  • 50
    Wijnhoven HA, Kriegsman DM, Hesselink AE, Penninx BW, De H aan M. Determinants of different dimensions of disease severity in asthma and COPD. pulmonary function and health-related quality of life. Chest 2001;119:10341042.
  • 51
    Van Den B oom G, Rutten-van Molken MP, Tirimanna PR, Van S chayck CP, Folgering H, Van W eel C. Association between health-related quality of life and consultation for respiratory symptoms: results from the DIMCA programme. Eur Respir J 1998;11:6772.
  • 52
    De G raaf - in ‘ t V eld T, Koenders S, Garrelds IM, Gerth van Wijk R. The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis. J Allergy Clin Immunol 1996;98:508513.
  • 53
    Barley EA, Jones PW. A comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma. Eur Respir J 1999;4:591596.
  • 54
    . Quality of life and clinical trials. Lancet 1995;346:12.
  • 55
    Ratner PH, Van B avel JH, Martin BG et al. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. J Fam Pract 1998;47:118125.
  • 56
    Canonica GW, Bousquet J, Morelli MC. Intranasal budesonide via turbuhaler versus fluticasone propionate aqueous nasal spray in once daily treatment for seasonal allergic rhinitis. J Allergy Clin Immunol 1998;101:S246.
  • 57
    Ostinelli J, Bousquet J. Effect of nasal steroids on general quality of life in seasonal allergic rhinitis. J Allergy Clin Immunol 1998;101:s243.
  • 58
    Van Der M olen T, Sears MR, De G raaff CS, Postma DS, Meyboom-de Jong B. Quality of life during formoterol treatment: comparison between asthma- specific and generic questionnaires. Canadain and the Dutch Formoterol Investigators. Eur Respir J 1998;12:3034.
  • 59
    De G raeff A, De L eeuw RJ, Ros WJ et al. A prospective study on quality of life of laryngeal cancer patients treated with radiotherapy. Head Neck 1999;21:291296.
  • 60
    Apter AJ, Reisine ST, Affleck G, Barrows E, Zuwallack RL. The influence of demographic and socioeconomic factors on health-related quality of life in asthma. J Allergy Clin Immunol 1999;103:7278.
  • 61
    Sawyer MG, Spurrier N, Whaites L, Kennedy D, Martin AJ, Baghurst P. The relationship between asthma severity, family functioning and the health-related quality of life of children with asthma. Qual Life Res 2000;9:11051115.
  • 62
    Mancuso CA, Peterson MG, Charlson ME. Effects of depressive symptoms on health-related quality of life in asthma patients. J General Intern Med 2000;15:301310.
  • 63
    Shedler J, Mayman M, Manis M. The illusion of mental health. Am Psychol 1993;48:11171131.
  • 64
    Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 2000;162:13911396.
  • 65
    Gerth Van Wijk R, Terreehorst IT, Duivenvoorden HJ et al. The impact of comorbidity on generic quality of life in house dust mite allergic patients. Allergy 2000;55:115.
  • 66
    Metson R, Gliklich RE. Clinical outcome of endoscopic surgery for frontal sinusitis. Arch Otolaryngol Head Neck Surg 1998;124:10901096.
  • 67
    Gliklich RE, Metson R. Effect of sinus surgery on quality of life. Otolaryngol Head Neck Surg 1997;117:1217.
  • 68
    Benninger MS, Senior BA. The development of the Rhinosinusitis Disability Index. Arch Otolaryngol Head Neck Surg 1997;123:11751179.
  • 69
    Piccirillo J, Edwards D, Haiduk A, Yonan C, Thawley S. Psychometric and clinimetric validity of the 31-Item Rhinosinusitis Outcome Measure (RSOM-31). Am J Rhinol 1995;9:927306.
  • 70
    Berdeaux G, Hervie C, Smajda C, Marquis P. Parental quality of life and recurrent ENT infections in their children: development of a questionnaire. Rhinitis Survey Group Qual Life Res 1998;7:501512.
  • 71
    Radenne F, Lamblin C, Vandezande LM et al. Quality of life in nasal polyposis. J Allergy Clin Immunol 1999;104:7984.
  • 72
    Xuan J, Kirchdoerfer LJ, Boyer JG, Norwood GJ. Effects of comorbidity on health-related quality-of-life scores: an analysis of clinical trial data. Clin Ther 1999;21:383403.
  • 73
    Diette GB, Markson L, Skinner EA, Nguyen TT, Algatt-Bergstrom P, Wu AW. Nocturnal asthma in children affects school attendance, school performance, and parents’ work attendance. Arch Pediatr Adolesc Med 2000;154:923928.
  • 74
    Spee-van der Wekke J, Meulmeester JF, Radder JJ, Verloove-Vanhorick SP. School absence and treatment in school children with respiratory symptoms in The Netherlands: data from the Child Health Monitoring System. J Epidemiol Community Health 1998;52:359363.
  • 75
    Jolicoeur LM, Boyer JG, Reeder CE, Turner J. Influence of asthma or allergies on the utilization of health care resources and quality of life of college students. J Asthma 1994;31:251267.
  • 76
    Simons FE. Learning impairment and allergic rhinitis. Allergy Asthma Proc 1996;17:185189.
  • 77
    Craig TJ, Teets S, Lehman EB, Chinchilli VM, Zwillich C. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 1998;101:633637.
  • 78
    Vuurman EF, Van V eggel LM, Uiterwijk MM, Leutner D, O'Hanlon JF. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 1993;71:121126.
  • 79
    Vuurman EF, Van V eggel LM, Sanders RL, Muntjewerff ND, O'Hanlon JF. Effects of semprex-D and diphenhydramine on learning in young adults with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1996;76:247252.
  • 80
    Milgrom H, Biondi R, Georgitis JW et al. Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children. Ann Allergy Asthma Immunol 1999;83:105111.
  • 81
    Ungar WJ, Coyte PC. Measuring productivity loss days in asthma patients. The Pharmacy Medication Monitoring Program Advisory Board. Health Econ 2000;9:3746.
  • 82
    Reijula K, Haahtela T, Klaukka T, Rantanen J. Incidence of occupational asthma and persistent asthma in young adults has increased in Finland. Chest 1996;110:5861.
  • 83
    Toren K, Brisman J, Olin AC, Blanc PD. Asthma on the job: work-related factors in new-onset asthma and in exacerbations of pre-existing asthma. Respir Med 2000;94:529535.
  • 84
    Blanc PD, Trupin L, Eisner M et al. The work impact of asthma and rhinitis: findings from a population-based survey. J Clin Epidemiol 2001;54:610618.
  • 85
    Malone DC, Lawson KA, Smith DH, Arrighi HM, Battista C. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol 1997;99:2227.
  • 86
    Fireman P. Treatment of allergic rhinitis: effect on occupation productivity and work force costs. Allergy Asthma Proc 1997;18:6367.
  • 87
    Gilmore TM, Alexander BH, Mueller BA, Rivara FP. Occupational injuries and medication use. Am J Ind Med 1996;30:234239.
  • 88
    Cockburn IM, Bailit HL, Berndt ER, Finkelstein SN. Loss of work productivity due to illness and medical treatment. J Occup Environ Med 1999;41:948953.
  • 89
    Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol 2001;107:38.
  • 90
    Ray NF, Baraniuk JN, Thamer M et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses. J Allergy Clin Immunol 1999;103:401407.
  • 91
    Socioeconomics. Global Initiative for Asthma. National Heart, Lung, and Blood. Institute, Publication no. 95. Bethesda, MD: National Institutes of Health, 1995: 3659.
  • 92
    Revicki DA, Leidy NK, Brennan-Diemer F, Thompson C, Togias A. Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index. Qual Life Res 1998;7:693702.
  • 93
    Revicki DA, Leidy NK, Brennan-Diemer F, Sorensen S, Togias A. Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest 1998;114:9981007.
  • 94
    Juniper EF, Norman GR, Cox FM, Roberts JN. Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma. Eur Respir J 2001;18:3844.
  • 95
    Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 2000;30:132140.
  • 96
    Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 1999;14:3238.
  • 97
    Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999;104:364369.
  • 98
    Siddiqui O, Ali MW. Linear structural equation model in analyzing quality-of-life-data from clinical trials. J Biopharm Stat 1999;9:661681.
  • 99
    Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. Jama 1994;272:619626.
  • 100
    Wood-Dauphinee S. Assessing quality of life in clinical research: from where have we come and where are we going? J Clin Epidemiol 1999;52:355363.
  • 101
    Williams JI. Ready, set, stop, and standing. J Clin Epidemiol 2000;53:2527.
  • 102
    Sintonen H, Puekurinen M. A generic 15 dimensional measure of health-related quality of life (15D). J Social Med 1989;26:8596.
  • 103
    Adams RJ, Ruffin RE, Smith BJ. Validity of a modified version of the Marks Asthma Quality of Life Questionnaire. J Asthma 2000;37:131143.
  • 104
    Barley EA, Quirk FH, Jones PW. Asthma health status measurement in clinical practice: validity of a new short and simple instrument. Respir Med 1998;92:12071214.
  • 105
    Bayliss MS, Espindle DM, Buchner D, Blaiss MS, Ware JE. A new tool for monitoring asthma outcomes: the ITG Asthma Short Form. Qual Life Res 2000;9:451466.
  • 106
    Creer TL, Wigal JK, Kotses H, McConnaughy K, Winder JA. A life activities questionnaire for adult asthma. J Asthma 1992;29:393399.
  • 107
    Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902907.
  • 108
    Katz PP, Yelin EH, Smith S, Blanc PD. Perceived control of asthma: development and validation of a questionnaire. Am J Respir Crit Care Med 1997;155:577582.
  • 109
    Letrait M, Lurie A, Bean K et al. The Asthma Impact Record (AIR) index: a rating scale to evaluate the quality of life of asthmatic patients in France. Eur Respir J 1996;9:11671173.
  • 110
    Mathias SD, Warren EH, Colwell HH, Sung JC. A new treatment satisfaction measure for asthmatics: a validation study. Qual Life Res 2000;9:873882.
  • 111
    Maille AR, Koning CJ, Zwinderman AH, Willems LN, Dijkman JH, Kaptein AA. The development of the ‘Quality-of-life for Respiratory Illness Questionnaire (QOL-RIQ)’: a disease-specific quality-of-life questionnaire for patients with mild to moderate chronic non-specific lung disease. Respir Med 1997;91:297309.
  • 112
    Schmid-Ott G, Kuensebeck HW, Jaeger B et al. Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients. Acta Derm Venereol 1999;79:443447.
  • 113
    Stangier U, Ehlers A, Gieler U. Der Marburger Hautfragebogen. In: Manual Zum Fragebogen Zur Bewaltigung Von Hautkrankheiten (FBH). Gottingen: Hogrefe, 1997.
  • 114
    Stein RE, Jessop DJ. Functional status II (R). A measure of child health status. Med Care 1990;28:10411055.
  • 115
    Eiser C, Vance YH, Seamark D. The development of a theoretically driven generic measure of quality of life for children aged 6–12 years: a preliminary report. Child Care Health Dev 2000;26:445456.
  • 116
    Rutishauser C, Sawyer SM, Bond L, Coffey C, Bowes G. Development and validation of the Adolescent Asthma Quality of Life Questionnaire (AAQOL). Eur Respir J 2001;17:5258.
  • 117
    Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in children with asthma. Qual Life Res 1996;5:3546.
  • 118
    Creer TL, Wigal JK, Kotses H, Hatala JC, McConnaughy K, Winder JA. A life activities questionnaire for childhood asthma. J Asthma 1993;30:467473.
  • 119
    Christie MJ, French D, Sowden A, West A. Development of child-centered disease-specific questionnaires for living with asthma. Psychosom Med 1993;55:541548.
  • 120
    French DJ, Christie MJ, Sowden AJ. The reproducibility of the Childhood Asthma Questionnaires: measures of quality of life for children with asthma aged 4–16 years. Qual Life Res 1994;3:215224.
  • 121
    Theunissen NC, Vogels TG, Koopman HM et al. The proxy problem: child report versus parent report in health-related quality of life research. Qual Life Res 1998;7:387397.
  • 122
    Vogels T, Verrips GH, Verloove-Vanhorick SP et al. Measuring health-related quality of life in children: the development of the TACQOL parent form. Qual Life Res 1998;7:457465.
  • 123
    Asmussen L, Olson LM, Grant EN, Fagan J, Weiss KB. Reliability and validity of the Children's Health Survey for Asthma. Pediatrics 1999;104:e71.
  • 124
    Asmussen L, Olson LM, Grant EN, Landgraf JM, Fagan J, Weiss KB. Use of the child health questionnaire in a sample of moderate and low-income inner-city children with asthma. Am J Respir Crit Care Med 2000;162:12151221.
  • 125
    Le C oq EM, Colland VT, Boeke AJ, Boeke P, Bezemer DP, Van E ijk JT. Reproducibility, construct validity, and responsiveness of the ‘How Are You?’ (HAY), a self-report quality of life questionnaire for children with asthma. J Asthma 2000;37:4358.
  • 126
    Le C oq EM, Boeke AJ, Bezemer PD, Bruil J, Van E ijk JT. Clinimetric properties of a parent report on their offspring's quality of life. J Clin Epidemiol 2000;53:139146.
  • 127
    Lewis - Jones MS, Finlay AY, Dykes PJ. The Infants' Dermatitis Quality Life Index. Br J Dermatol 2001;144:104110.
  • 128
    Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in the parents of children with asthma. Qual Life Res 1996;5:2734.
  • 129
    Osman LM, Baxter-Jones AD, Helms PJ. Parents' quality of life and respiratory symptoms in young children with mild wheeze. EASE Study Group. Eur Respir J 2001;17:254258.